Delivery Order SPE2DB22D2103-SPE2DB25FR9ML
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,737.07 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/mL 3mL insulin pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $6,033.64 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's qualification to compete in open federal...
- The Defense Logistics Agency awarded a $3,071.37 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This firm fixed-price contract, which is scheduled for completion by August 20, 2025, represents a routine pharmaceutical procurement supporting military healthcare operations. The award was made on a competitive basis without any set-aside designation, and performance will be executed from the contractor's facility...
- The Defense Logistics Agency awarded a delivery order valued at approximately $74,717 to AmerisourceBergen Drug Corp for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes a firm fixed price structure and carries no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $4,222.74 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml insulin pens (3ml). This contract, awarded on July 21, 2025, represents a firm fixed-price procurement with an ultimate completion date of July 22, 2025. The award was not set-aside and was competitively awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at...
- The Defense Logistics Agency awarded a delivery order valued at $5,907.21 to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This firm fixed price, non-competitive delivery order was issued on July 7, 2025, with an ultimate completion date of July 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a branded insulin medication used for diabetes management within the military and federal...
- The Defense Logistics Agency awarded a $4,152.30 delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 Unit/ML 3ML insulin pens on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,384.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tresiba FlexTouch 100 Unit/ML 3ML insulin pens. This is a non-set-aside contract with an ultimate completion date of August 13, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,582.33 and a firm fixed price structure. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $2,768.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 100 Unit/mL 3mL insulin pens, with an ultimate completion date of July 30, 2025. This non-set-aside contract represents a competitively awarded transaction executed on July 29, 2025, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9MLDelivery Order
The Defense Logistics Agency awarded a $67,932.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tresiba FlexTouch 200 unit/ml 3ml insulin pens, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award was issued on July 14, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Tresiba is a long-acting basal insulin used in diabetes management, reflecting the agency's ongoing procurement of pharmaceutical products to support military healthcare systems and the Defense Health Agency's medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to military healthcare programs worldwide. AmerisourceBergen's competitive positioning reflects its status as a major pharmaceutical distributor and established federal vendor, with demonstrated capability to fulfill both routine and specialized medical procurement requirements for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $67.9k | 7/14/25 |